Age-Related Macular Degeneration

Gene therapy has been around for decades now, but it has had a history of challenges with only a few breakthroughs.

PHILADELPHIA — The epidemic of age-related macular degeneration is expected to increase, according to a speaker here.

There was no statistically significant difference in mean visual acuity or mean spherical equivalent refraction in low vision patients when measured by instant vision assessment device vs. subjective refraction, according to a study.

Three patients in Italy have been successfully implanted with SING IMT, an implantable miniature telescope that improves vision in late-stage age-related macular degeneration, according to a press release from Samsara Vision.

In this episode, Nicole Fram, MD, MPH, sits down with hosts, Jim Mazzo and John A. Hovanesian, MD, FACS, to discuss taking over as managing partner for Advanced Vision Care and Samuel Masket, MD, and shares her take on new products and technologies in eye care.

WAIKOLOA, Hawaii — At Hawaiian Eye 2022, Nancy Lurker, president and CEO of EyePoint Pharmaceuticals, discusses data from the Phase 1 DAVIO study of EYP-1901 for wet-AMD.

ONL Therapeutics has closed its second tranche of Series B financing, which totaled $46.9 million, according to a press release.

Novel therapies for patients with age-related macular degeneration as well as the impact of the COVID-19 pandemic on treatment for this population were popular topics at ophthalmology meetings in 2021.

Age-related macular degeneration is a condition that requires regular monitoring in order to preserve vision and detect any changes in the eye.

Gene therapy could have the potential to revolutionize the treatment of many conditions, including age-related macular degeneration.